[ad_1]
The companies Pfizer Y BioNTech announced today, Monday, that they presented application to the European Medicines Agency (European Medicines Agency) for conditional approval of your vaccine. The Agency has been implementing large-scale clinical trial data for the Pfizer / BioNTech vaccine since October.
The request to the EMA comes after the corresponding request to the US. FDA on November 20, a measure that brought the two companies one step closer to delivering their vaccine.
According to confidential documents leaked to the FT, on its schedule last week, the EMA December 22that best to formulate your opinion on the Pfizer / BioNTech and Moderna vaccines. According to the schedule discussed yesterday, this date can be moved.
According to other confidential documents from yesterday’s discussions, FT’s evaluation of its vaccine Modern placed on January 12.
However, in the first announcement that followed the Covid-19 vaccine authorization applications, the European Medicines Agency stated that the vaccine authorization evaluations for Pfizer and Moderna would be completed in December. Specially in December 12th for Modern vaccine and in December 29 for his vaccine Pfizer.
